My Size vs Exascale Labs
MYSZ and XLAB side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MYSZ and XLAB compare
My Size is the larger company, worth 154 times as much as Exascale Labs ($495K against $3.2K).
Exascale Labs grew revenue faster over the last twelve months (111% versus 67.3% for My Size).
My Size keeps more of each dollar of sales as profit, with a net margin of −66.7% compared with −82.1% at Exascale Labs.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MYSZ | XLAB |
|---|---|---|
| Size and price | ||
| Market cap | $495K | $3.2K |
| Share price | $0.679 | $2.14 |
| Change, 1 year | −92.6% | −78.7% |
| Change, 5 years | −99.9% | – |
| Beta (5Y) | 0.96 | −0.74 |
| Employees | 45 | 12 |
| StockData Score | ||
| Total score | 7 | 7 |
| Valuation score | 3 (better) | 1 |
| Growth score | 2 | 2 |
| Performance score | 1 (better) | 0 |
| Health score | 1 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.0× | 0.0× (better) |
| P/B | 0.2× | – |
| FCF yield | −995% | – |
| Fair value | $15.23 | – |
| Margin of safety | 95.5% | – |
| Growth | ||
| Revenue growth (TTM) | 67.3% | 111% (better) |
| Revenue growth, 5Y average | 131% | – |
| Profitability | ||
| Gross margin | 29.7% (better) | 16.3% |
| Operating margin | −63.7% | −32.4% (better) |
| Net margin | −66.7% (better) | −82.1% |
| FCF margin | −43.4% | – |
| Return on equity | −155% | – |
| Return on invested capital | −185% | – |
| Financial health | ||
| Debt / equity | 0.42 | – |
| Current ratio | 1.29 (better) | 0.20 |
| Altman Z-score | −17.43 | −9.96 (better) |
| Piotroski F-score | 2 | 5 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 3.2% | – |
| Held by insiders | – | 7.7% |
| Insider net buying, 12 months | $5.3K | – |
Go deeper
- MYSZ stock overview
- MYSZ income statement
- MYSZ valuation and score
- XLAB stock overview
- XLAB income statement
- XLAB valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.